Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1998 3
1999 3
2000 2
2001 2
2002 6
2003 3
2004 1
2008 2
2009 2
2011 2
2012 3
2013 5
2014 1
2015 2
2016 2
2017 7
2018 6
2019 5
2020 3
2021 4
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG. Drilon A, et al. Among authors: multani ps. Cancer Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9. Cancer Discov. 2017. PMID: 28183697 Free PMC article. Clinical Trial.
Rituximab.
Multani P, White CA. Multani P, et al. Cancer Chemother Biol Response Modif. 2003;21:235-58. Cancer Chemother Biol Response Modif. 2003. PMID: 15338748 Review. No abstract available.
Antimetabolites.
Grem JL, Takimoto CH, Multani P, Chu E, Ryan D, Chabner BA, Allegra CJ, Johnston PG. Grem JL, et al. Among authors: multani p. Cancer Chemother Biol Response Modif. 1999;18:1-38. Cancer Chemother Biol Response Modif. 1999. PMID: 10800475 Review. No abstract available.
Melanoma.
Haluska FG, Multani PS. Haluska FG, et al. Among authors: multani ps. Cancer Chemother Biol Response Modif. 1999;18:470-88. Cancer Chemother Biol Response Modif. 1999. PMID: 10800498 Review.
Choroidal thickness in Waardenburg syndrome.
Rishi P, Multani P, Prasan VV, Rishi E, Attiku Y. Rishi P, et al. Among authors: multani p. GMS Ophthalmol Cases. 2019 Jun 18;9:Doc22. doi: 10.3205/oc000111. eCollection 2019. GMS Ophthalmol Cases. 2019. PMID: 31355120 Free PMC article.
The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela.
Bowe T, Nyamai L, Ademola-Popoola D, Amphornphruet A, Anzures R, Cernichiaro-Espinosa LA, Duke R, Duran F, Martinez-Castellanos MA, Multani PK, Nitulescu CE, Padhi TR, Tipsuriyaporn B, Chan RVP, Campbell JP, Yonekawa Y. Bowe T, et al. Among authors: multani pk. Digit J Ophthalmol. 2019 Oct 12;25(4):49-58. doi: 10.5693/djo.01.2019.08.002. eCollection 2019 Apr. Digit J Ophthalmol. 2019. PMID: 32076388 Free PMC article. Review.
61 results